Laboratory of Medicinal Chemistry, Endocrinology and Genomic Unit, CHUQ-(CHUL) Research Center, 2705 Laurier Boulevard, Quebec, QC, G1V 4G2, Canada.
Mol Divers. 2011 May;15(2):317-39. doi: 10.1007/s11030-010-9273-2. Epub 2010 Sep 9.
Libraries of steroid derivatives with two levels of molecular diversity were prepared to optimize the antiproliferative activity on leukemia HL-60 cells by first varying the amino acid (AA) at R(1) (libraries A, B, C, and D: with 45, 45, 20, and 20 members, respectively) and, subsequently, the capping group at R(2) (library E: 168 members). The screening of these aminosteroids revealed interesting structure-activity relationships. In library A, the compounds bearing a tetrahydroisoquinolone residue as the first element of diversity showed potent cytotoxicity, principally when isovaleric or cyclohexyl acetic acid was used as a capping group (>40% of cell growth inhibition at 1 μM). In library B, the phenylalanine (Phe) derivatives bearing a cyano group induced a higher growth inhibition than the other Phe derivatives. The screening of library C indicated the increase of hydrophobicity of proline (Pro) seems to preserve the cytotoxic effect achieved by the lead compound. However, the synthesis of structural Pro variants (library D) clearly shows weaker activities when compared to L-Pro building blocks. Finally, by incorporating some of the most active AA of libraries A-D in library E, we observed that the amide coupling functionality gave stronger cytotoxic activity compared to the corresponding sulfonamides or benzylamines. Six of the most active amide derivatives (E-37P, E-41P, E-42P, E-46P, E-48F, and E-12T) were selected and IC(50) determined on HL-60 cells as well as on normal human lymphocytes. Among this series of new anticancer agents, good to high selectivity indices (SI = IC(50) (lymphocytes)/IC(50) (HL-60 cells) = 5 - 55) were obtained.
用两种分子多样性水平的甾体衍生物文库来优化对白血病 HL-60 细胞的抗增殖活性,首先改变 R(1)位的氨基酸(AA)(文库 A、B、C 和 D:分别有 45、45、20 和 20 个成员),然后改变 R(2)位的封端基团(文库 E:有 168 个成员)。对这些氨基甾体的筛选揭示了有趣的构效关系。在文库 A 中,第一个多样性元素为四氢异喹啉残基的化合物表现出很强的细胞毒性,主要是当异戊酸或环己基乙酸用作封端基团时(在 1 μM 时超过 40%的细胞生长抑制)。在文库 B 中,带氰基的苯丙氨酸(Phe)衍生物比其他 Phe 衍生物诱导更高的生长抑制。文库 C 的筛选表明脯氨酸(Pro)的疏水性增加似乎保持了先导化合物的细胞毒性效应。然而,与 L-Pro 构建块相比,结构 Pro 变体(文库 D)的合成明显显示出较弱的活性。最后,通过将文库 A-D 中最活跃的 AA 中的一些整合到文库 E 中,我们观察到酰胺偶联官能团比相应的磺酰胺或苄胺具有更强的细胞毒性活性。从最活跃的酰胺衍生物(E-37P、E-41P、E-42P、E-46P、E-48F 和 E-12T)中选择了 6 个,并在 HL-60 细胞和正常人类淋巴细胞上测定了 IC(50)。在这一系列新的抗癌药物中,获得了良好至高的选择性指数(SI = IC(50)(淋巴细胞)/IC(50)(HL-60 细胞)= 5-55)。